701232-66-8

Basic information

• Product Name: Acetic acid, 2-[4-(4-hydroxyphenyl)cyclohexylidene]-, Methyl ester
• Synonyms: Acetic acid, 2-[4-(4-hydroxyphenyl)cyclohexylidene]-, Methyl ester
• CAS NO: 701232-66-8
• Molecular Formula: C₁₅H₁₈O₃
• Molecular Weight: 246.30162
• Mol File: 701232-66-8.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Acetic acid, 2-[4-(4-hydroxyphenyl)cyclohexylidene]-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, 2-[4-(4-hydroxyphenyl)cyclohexylidene]-, Methyl ester(701232-66-8)
• EPA Substance Registry System: Acetic acid, 2-[4-(4-hydroxyphenyl)cyclohexylidene]-, Methyl ester(701232-66-8)

Safety Data

• Hazardous Substances Data: 701232-66-8(Hazardous Substances Data)

Upstream product

• 105640-07-1 4-(4-hydroxyphenyl)cyclohexan-1-one 
• 1067-74-9 Methyl diethylphosphonoacetate 
• 5927-18-4 trimethyl phosphonoacetate 
• 80-70-6 N,N,N',N'-tetramethylguanidine 

Downstream Products

• 701232-67-9 trans-[4-(4-hydroxyphenyl)cyclohexyl]acetic methyl ester 
• 1414867-53-0 1-O-({trans-4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetyl)-β-D-glucopyranuronic acid 
• 1414867-52-9 prop-2-en-1-yl 1-O-({trans-4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetyl)-β-D-glucopyranuronate 

Relevant articles and documents

Proton exchange reactions in isotope chemistry (II) synthesis of stable isotope-labeled LCQ908

The proton exchange reaction was applied to the preparation of stable isotope-labeled LCQ908. For this synthesis, a suitable intermediate with protons alpha to a carbonyl group was first subjected to the H-D exchange reaction; subsequent coupling of a car

Development of novel benzomorpholine class of diacylglycerol acyltransferase i inhibitors

Diacylglycerol acyltransferase 1 (DGAT1) presents itself as a potential therapeutic target for obesity and diabetes for its important role in triglyceride biosynthesis. Herein we report the rational design of a novel class of DGAT1 inhibitors featuring a

4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5, 4 -F] [1, 4] OXAZEPINE COMPOUNDS AS DGAT1 INHIBITORS

Described herein are compounds of formula (I). The compounds of formula (I) act as DGAT1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.